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Abstract
Purpose The London Child Health and Development
Study (CHADS) is a prospective, longitudinal investi-
gation of children, sampled from the general community
aged 9–11 years and assessed biennially, who present
premorbid risk markers for schizophrenia. The study
aims to characterise developmental trajectories of psy-
chological, cognitive, and biological functioning in at-
risk children and identify potential targets for early
preventative intervention. This review summarises
CHADS findings, discusses these in the context of recent
theory regarding aetiology and prevention of
schizophrenia, and highlights challenges to be addressed
with future research.
Methods We review (1) epidemiological information
on the prevalence and correlates of developmental
antecedents of schizophrenia in the general child popu-
lation, (2) evidence of psychosocial, cognitive, and
biological dysfunctions in at-risk children presenting
multiple antecedents of schizophrenia and at-risk chil-
dren with a family history of schizophrenia, and (3)
related findings from an associated sample of help-
seeking children receiving intervention.
Results Community-based screening of 9–11-year olds
identified *9 % with a triad of antecedents of
schizophrenia [including psychotic-like experiences
(PLEs)] who are putatively at-risk of psychosis; these
children reported greater exposure and responsivity to
stressors, impairments in general intelligence and specific
cognitive functions, brain structure and function abnor-
malities, and neuromotor dysfunction. Preliminary evi-
dence suggests distressing PLEs are a viable target for
cognitive-behavioural intervention in at-risk children.
Conclusions Intervention in early, premorbid phases of
illness might alleviate current difficulties and avert future
schizophrenia using benign treatments. The CHADS pro-
gramme has identified several markers that may index early
pathophysiology and constitute potential targets for pre-
ventative intervention.
Keywords Psychosis  High-risk  Developmental
psychopathology  Psychotic-like experiences 
Adolescence
Introduction
Over the past two decades, considerable research and
clinical effort has been invested in devising methods of
early detection and intervention for psychosis, with the
aims of delaying, ameliorating, and ultimately preventing,
illness onset [1]. This work has focussed predominantly on
the identification and treatment of symptomatic, help-
seeking individuals purportedly experiencing the
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prodromal phase of illness that immediately precedes the
onset of frank psychosis, typically during later adolescence
or early adulthood. Within 2–3 years of presentation, a
third of these ‘‘clinically high risk (CHR)1’’ individuals
transition to psychotic illness [2]; a substantial proportion
continue to experience persistent psychopathology, marked
psychosocial impairment, and compromised quality of life;
and only a third experience clinical remission [3]. This
trajectory of persisting or worsening functional disability
for the majority underscores a need for earlier intervention.
That is, preventing psychosis and associated adverse out-
comes might be more effective if we could identify at-risk
individuals in the premorbid phase of illness, prior to the
advent of the significant disability that characterises the
prodrome, and without restriction to those accessing health
services. Motivated by this aspiration, the London Child
Health and Development Study (CHADS) was designed as
a prospective, longitudinal, observational investigation of a
cohort of children sampled from the general community at
age 9–11 years, and enriched with individuals putatively at
high risk for developing schizophrenia and the spectrum
disorders (SSD). The primary goal of the study was to
characterise developmental trajectories of at-risk individ-
uals through adolescence and into young adulthood, with
the aim of determining markers of evolving disease that, in
the longer term, might be targeted with early, preventative
interventions.
Established methods for the identification of individ-
uals potentially experiencing the psychosis prodrome are
based on clinical assessment of help-seeking individu-
als.2 Our research required a new method for prospec-
tively identifying at-risk children in the premorbid phase
of illness via screening of the general population.
Although family history of schizophrenia represents the
most established of risk markers for the illness
(*10–15 % of individuals with a first-degree relative
with schizophrenia develop the disorder), a lack of
family history for the majority with schizophrenia [6]
renders this a limited means of identifying at-risk indi-
viduals in the population. During 2004–2005, we there-
fore piloted a novel method of screening community
samples in the United Kingdom (UK), using self- and
caregiver-report questionnaires [7], to identify putatively
at-risk children who presented multiple, replicated,
developmental antecedents of schizophrenia. These
antecedents, identified in previous prospective longitu-
dinal investigations as distinguishing children who later
developed SSD from those who did not [8–10], are
thought to represent early manifestations of the disease
pathology (compared to ‘‘risk factors’’, which may be
conceptualised as more passive markers of increased
risk). As these antecedents are not specific for SSD rel-
ative to other adult psychiatric disorders (albeit their
association with SSD is typically of greater relative
magnitude), we reasoned that a combination of ante-
cedents would identify putatively at-risk children with
greater sensitivity and specificity than any single ante-
cedent. Our brief questionnaire provided a cost-effective
means of screening large numbers of children in the
general population for the antecedents within a primary
school setting, with sampling restricted to children aged
9 years and older so as to obtain reliable and valid self-
reports. As some of the strongest and/or most replicated
antecedents of SSD identified in systematic reviews [8–
10] are not amenable to accurate assessment via ques-
tionnaire (e.g. obstetric complications, premorbid intel-
lectual [IQ] deficits), our questionnaire incorporated
antecedents that were strongly associated with later
schizophrenia and suited to questionnaire assessment.3
We additionally assessed family history of mental health
problems (including SSD).
Within the CHADS programme, children completing
questionnaire screening provided a community sample
(cross-sectional data) from which several longitudinal
cohorts were convened, including (1) an unselected com-
munity sample of children who have been assessed spo-
radically using questionnaires and interviews, and (2) a
selected sample of children who have completed detailed
laboratory-based assessments biennially. This review
summarises CHADS findings published to date, including
epidemiological findings (from the community cohorts)
and psychological, cognitive, and neurobiological findings
(from the selected longitudinal cohort), as well as findings
1 The CHR state is also known as the ‘‘at-risk mental state’’ (ARMS)
and ‘‘ultra-high-risk’’ (UHR) state [1].
2 Established methods (reviewed in [1]) for the identification of
individuals in this prodromal phase include the complementary UHR
[4] and basic symptoms [5] criteria assessed via clinical interview,
with the latter possibly identifying an earlier phase of the prodromal
state than UHR criteria.
3 Items assessed psychotic-like experiences (child- and caregiver-
report), internalising and externalising psychopathology (emotional
symptoms, peer relationship problems, conduct problems, and
hyperactivity–inattention; child- and caregiver-report using the
Strengths and Difficulties Questionnaire [11, 12]), and delays or
abnormalities in speech and/or motor milestone development (care-
giver-report). Additional items assessed family history of mental
health problems including SSD (caregiver-report), and demographic
items (child- and caregiver-report). See Table 2 (screening phase) for
further detail.
476 Soc Psychiatry Psychiatr Epidemiol (2016) 51:475–491
123
from an associated sample of help-seeking children
receiving intervention, discusses these findings in the
context of recent theory regarding aetiology and prevention
of SSD, and outlines challenges remaining for future
research.
Methods
Table 1 summarises the community and selected cohorts
incorporated within the CHADS programme and their
associated publications.
Table 1 Summary of CHADS programme cohort characteristics (pilot, community, selected, and associated intervention cohorts) and associated
publications
CHADS cohort Sample characteristics Associated
publications
1. Pilot study sample
(2004–2005)
548 children aged 9–11 years (mean age 10.6 years; 54.7 % female) and 264
primary caregivers, comprising:
129 children and caregivers who completed questionnaires via General Practitioner
surgeries (21.6 % of 597 children enrolled at collaborating surgeries)
421 children (97.7 % of children eligible) who completed questionnaires in school
class and 136 caregivers (32.3 %)
[7]
2a. Community sample
(screening)
7966 children completing questionnaires anonymously in school class (94.6 % of
children eligible; mean age 10.4 years; 49.2 % female) and 1504 primary
caregivers (18.9 %)
[9, 17, 85] (subset of
sample); [15]
2b. Longitudinal community
sample
670 children and caregivers (mean age 10.3 years; 53.4 % female)—the subset of
799 families who provided identities and contact information at screening and
whose contact information remained valid at first reassessment approximately
2 years later
[27, 28, 73]
3. Longitudinal selected sample
(biennial assessments)
111 children and caregivers, comprising:
46 TD; 33 ASz; 26 FHx; and 6 children meeting both ASz and FHx criteriaa
Biennial assessments completed at ages 9–12 years (baseline); 11–14 years (follow-
up 1); 13–16 years (follow-up 2); and 17–18 years (follow-up 3)
(Note: a further 39 children with alternative illness risk profiles, including bipolar
disorder, were recruited in insufficient numbers to provide viable groups for
examination)
[30, 34, 35, 39, 43, 48,
52, 53, 55, 56]
4. CHADS-associated
intervention samples
Clinical case series: four children from the community sample who completed a
new, manualised cognitive behavioural intervention for children presenting
psychotic-like experiences and emotional distress
[74]
Coping with unusual experiences for children study (CUES): doi 10.1186/
ISRCTN13766770 (Lead: Dr. S. Jolley)—for children aged 8–14 years presenting
to Child and Adolescent Mental Health Services with unusual experiences and
emotional distress
[75–78]
Coping with unusual experiences for 12–18 (CUES?): doi 10.1186/
ISRCTN21802136 (Lead: Dr. S. Jolley)—for users of adolescent community
mental health services (aged 12–18 years) who report distressing unusual
experiences
CHADS London Child Health and Development Study, TD typically developing children, ASz children presenting a triad of developmental
antecedents of schizophrenia, FHx children with a family history of schizophrenia/schizoaffective disorder
a Includes eight FHx children recruited via contact with patients receiving treatment in the local health service rather than via school screening
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Community (cross-sectional and longitudinal)
cohorts
Our sampling and recruitment strategies are detailed else-
where [7, 9]. Briefly, during 2005–2010, children aged
9–11 years were sampled from 73 collaborating primary
schools within Greater London.4 Children (n = 7966;
95 % of eligible children) completed questionnaires inde-
pendently and anonymously in class, with items read aloud
by a researcher. Caregivers completed corresponding
questionnaires (matched by code) at home and returned
them via reply-paid mail (n = 1504); this constituted the
cross-sectional community sample [Table 1, ‘‘2a. Com-
munity sample (screening)’’].
Caregivers were invited to provide child and caregiver
identities and contact information, indicating their willingness
to consider further research participation (n = 799 families).
A longitudinal community sub-cohort (Table 1, ‘‘2b. Longi-
tudinal community sample’’) was derived from the screening
sample and assessed for representativeness,5 with sampling
weights applied in analyses where appropriate.
Selected longitudinal cohort
From the screening questionnaires, a triad of antecedents of
schizophrenia (ASz) were defined to include: (1) child-re-
ported subclinical psychotic symptoms [or psychotic-like
experiences (PLEs)], (2) child-reported emotional symptoms
and/or caregiver-reported behavioural or social problems, and
(3) caregiver-reported delays or abnormalities in speech and/
or motor development [7, 9]. Three groups of children were
recruited from the community screening sample and followed
with biennial assessments that measured psychological, cog-
nitive, and biological features previously shown to be char-
acteristic features of adults with schizophrenia, forming a
longitudinal selected sample of 111 children (Table 1, ‘‘3.
Longitudinal selected sample (biennial assessments)’’). The
groups incorporated two high risk groups, namely children
presenting the antecedent triad (ASz group) and children with
a family history (in first- or second-degree relatives) of
schizophrenia or schizoaffective disorder (FHx group), as
well as a group of low risk, typically developing children who
presented no antecedents or family history of schizophrenia
(TD group). Table 2 details the measures included in the five
assessment phases conducted to date in this selected cohort.6
Related intervention cohorts
We additionally summarise findings obtained to date from
CHADS-associated intervention research with help-seek-
ing children (Table 1, ‘‘4. CHADS-associated intervention
samples’’); that is, children identified through mental health
services and not community screening.
Results
Epidemiological findings
Data from our CHADS cross-sectional and longitudinal
community sampling have provided important epidemio-
logical information concerning the prevalence and corre-
lates of developmental antecedents of schizophrenia in the
general child population, particularly PLEs.
Developmental antecedents of SSD
Consistent with the elevated incidence of schizophrenia in
the London community from which our sample was drawn
[16], more than three quarters of children aged 9–11 years
experienced at least one of the antecedents within the triad
(Fig. 1), with just under a tenth (9.4 %) presenting all
three. Caregiver reports of a family history of
4 Collaborating schools spanned the range of socio-economic disad-
vantage represented in London schools (as indexed by eligibility of
children to receive free school meals; with oversampling of deprived
inner-London communities) and included state and religious schools
of variable enrolment size. Eighty percent of children attended school
within the inner-city London Boroughs of Lambeth* (35.1 %),
Southwark* (22.1 %), Lewisham* (18.6 %), Tower Hamlets*
(2.6 %), and Westminster (1.6 %), with the remaining fifth sampled
from the outer London Boroughs of Croydon (8.5 %), Bromley
(7.0 %), Brent* (3.2 %), and Harrow (1.4 %). Boroughs indicated by
* are among the most deprived 10 % of all English local authorities
according to the Index of Multiple Deprivation 2010 [13] and the
lowest scoring 10 % on the Local Index of Child Well-Being [14].
School-level data obtained from the Office for National Statistics at
the time of sampling indexed the socio-economic status and ethnic
diversity of the sample: On average, 31.2 % of children in partici-
pating schools were eligible to receive free school meals (range
1.9–62.2 %; cf. Greater London average 25.3 %, and England
average 15.8 %); 24.9 % of children were of white British ethnicity
(range 0–80.8 %; cf. Greater London average 37.1 %, and England
average 80.3 %), with the remainder of black (45.2 %), Asian
(11.4 %), other white (9.0 %), or other (9.5 %) ethnicities.
5 Representative indices (by child self-report) include basic demo-
graphic information (age, sex), PLEs [7, 15], and emotional
symptoms, peer relationship problems, conduct problems, and
hyperactivity–inattention [11, 12]. Few differences between the
cross-sectional and longitudinal community samples are notable on
these measures (see primary publications and [9]).
6 Assessment phases in the longitudinal selected sample include:
screening (9–11 years), baseline (9–12 years), and first
(11–14 years), second (13–16 years), and third follow-up
(17–18 years). Measures that were assessed more widely, in the
longitudinal community sample, are indicated in Table 2 using the
symbol ‘‘?’’. The initial questionnaire assessment which provided
cross-sectional data in the community sample (from which the
longitudinal community sample and longitudinal selected samples
were derived) is summarised under the screening phase.
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Table 2 Summary of the assessments completed with the longitudinal selected sample at each assessment phase
Domain Assessment method
(informant)
Assessment
instrument
Assessment phase
SCR BL FU1 FU2 FU3a
Psychopathology
Social, emotional, and
behavioural problems
Questionnaire (P, C,
T)
Strengths and Difficulties Questionnaire (SDQ [11, 12, 86]):
psychopathology scales (emotional symptoms, peer
relationship problems, conduct problems, hyperactivity–
inattention), prosocial behaviour scale, and supplement
assessing impact of psychopathology
4 4 4? 4 4
DSM-IV diagnoses and
symptoms (including
psychotic symptoms)
Interview (P, C) Kiddie Schedule for Affective Disorders and Schizophrenia—
Present and Lifetime version (K-SADS-PL) [87] [primary
caregiver: full schedule; child: anxiety and psychotic
symptoms (screening and supplement) questions only]
– 4 – – –
Questionnaire (P, C,
& T)
Achenbach System of Empirically Based Assessment
(ASEBA [88]): Child Behavior Checklist (CBCL), Youth
Self-Report (YSR), Teacher Report Form (TRF)
– 4 4 4 4
Anxiety symptoms Questionnaire (C) Revised Child Manifest Anxiety Scale, second edition
(RCMAS-2 [89])
– 4 4 4 –
Depressive symptoms Questionnaire (C) Beck Depression Inventory for Youth (BDI-Y [90]) – 4 4 4 –
Antisocial traits Questionnaire (P, C) Antisocial Process Screening Device [91] – 4 4 4 –
Autistic symptoms Questionnaire (P) Social Communication Questionnaire—lifetime version [92] – 4 – – –
Psychotic-like experiences Questionnaire (P, C) Psychotic-Like Experiences (PLE) Questionnaire [7, 15]:
items assessing hallucination- and delusion-like experiences,
and associated impact
4 4 4? 4 4
Prodromal symptoms of
psychosis
Questionnaire (C) Prodromal Questionnaire [93] – – – 4 4
Psychotic symptoms Interview (C) Comprehensive Assessment of At-Risk Mental State
(CAARMS [94])
– – – – 4
Personality Questionnaire (P) Big Five Inventory [95] adapted for Children – – – 4 –
Global functioning Interview (C) Global Assessment of Functioning scale (GAF [96]) – 4 – – 4
Medical and developmental history
Developmental delays Questionnaire (P) Items assessing delays/problems in the attainment of speech or
motor milestones [7]
4 – – – –
Medical and psychiatric
history
Interview (C) Family Interview for Genetic Studies (FIGS [97]) to identify
known medical and psychiatric conditions in the child and
other family members
– 4 4 4 –
Relationships assessment
Parenting practices Questionnaire (P, C) Alabama Parenting Questionnaire [98] – 4 4 4 –
Family functioning Questionnaire (P) McMaster Family Assessment Device [99] – – – 4 –
Expressed emotion Standardised rating
(P)
Expressed emotion rating scale (coded from video recording)
[100, 101]
– 4 4 4 –
Child experiences
Alcohol and drug use Questionnaire (C) Adapted version of the Edinburgh Study of Youth Transitions
and Crime alcohol and drug use questionnaires [102]
– 4 4 4 4
Daily hassles and life
events
Questionnaire (C) Adapted version of a daily school-related hassles and negative
life events questionnaire [103]
– 4 4 4 –
Threatening life events Questionnaire (C) List of Threatening Events (LTE [104]) – – – – 4
Perceived stress Questionnaire (C) Perceived Stress Scale (PSS [105]) – – – – 4
Childhood trauma Questionnaire (C) Childhood Trauma Questionnaire (CTQ [106]) – – – – 4
Victimisation Interview (C) Juvenile Victimization Questionnaire 2nd revision (JVQ-R2
[107])—sections on victimisation by peers and siblings,
internet/mobile harassment, and discriminatory attacks
– – – – 4
Self-harm Questionnaire (C) Item assessing self-harm in the past 12 months [108] – – – – 4
Socio-environmental indices
Sociodemographic
variables
Questionnaire (P, C) Items assessing child’s sex, date of birth, and (by caregiver-
report only) child’s self-ascribed ethnicity, parents’ dates
and places of birth, child and family history of mental health
problems, and whether child had ever lived outside London
4 – – – –
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Table 2 continued
Domain Assessment method
(informant)
Assessment
instrument
Assessment phase
SCR BL FU1 FU2 FU3a
Ethnicity Questionnaire (P) Office of Population Censuses and Surveys method of self-
ascription (2001 census)
– 4 4 4 –
Migration history Questionnaire (P) Date of migration and country of origin – 4 4 4 –
Home, school, and
community supports
Questionnaire (C) Middle Development Index items [109] – 4 4 4 –
Sociodemographic context Questionnaire (P) UK Medical Research Council Sociodemographic Schedule
on housing and living (migration) circumstances; religious
engagement
– 4 4 4 –
Socio-economic Status Questionnaire (P) National Statistics Socio-Economic Classification (NS-SEC
[110]); household income; educational attainment
– 4 4 4 –
Financial income Questionnaire (C) Items assessing income sources and total income per week – – – – 4
Biological indices
DNA/mRNA Buccal sample (C) Collected at the research session and in home environment – 4 4 4 4
Blood sample (C) Collected at the research session – 4 4 4 4
Cortisol Saliva samples (C);
hair sample (C)
Home collection of multiple saliva samples throughout the day
at FU2 [43]; hair sample collected in the research session at
FU3
– – 4 – 4
Pubertal status Questionnaire (P, C) Pubertal Development Scale [111] – 4 4 4 –
Neuromotor function
Laterality/handedness Questionnaire (C) Annett Hand Preference Questionnaire [112], plus items from
the Edinburgh Handedness Inventory [113] and Coren’s
Lateral Preference Scale [114]
– 4 4 4 –
Gross and fine motor skills Standardised test (C) Purdue Pegboard [115] – 4 4 4 –
Involuntary dyskinetic
movements
Standardised rating
(C)
Dyskinesia Identification System Condensed User Scale [116]
(coded from video recording)
– 4 – – –
Brain structure and function
General intelligence Standardised test (C) Wechsler Abbreviated Scale of Intelligence (WASI [117]) – 4 4 4 4
Scholastic achievement Standardised test (C) Wechsler Individual Achievement Test 2nd UK edition
(WIAT [118]): word reading, numerical operations, and
spelling subtests
– 4 4 4 –
Processing speed Standardised test (C) Symbol Digit Modality Test [119] – – – 4 –
Memory Standardised test (C) Wide Range Assessment of Memory and Learning 2nd edition
(WRAML2 [120]): verbal learning and memory, visual
learning and memory, verbal delayed recall, recognition
(verbal and nonverbal), and working memory subtests
– 4 4 4 –
Executive function Standardised test (C) Delis-Kaplan Executive Function System (D-KEFS [121]):
verbal fluency, colour–word interference (Stroop), and tower
test subtests
– 4 4 4 –
Facial emotion
recognition
Computer task (C) Penn Emotion Discrimination Task (EmoDiff40) [122] – 4 4 4 –
Facial emotion
discrimination
Computer task (C) Emotion Recognition Test–40 Faces version (ER-40) [123] – 4 4 4 –
Brain structure Magnetic Resonance
Imaging (C)
Spoiled Gradient Recalled acquisition (Magnetization
Prepared Rapid Acquisition Gradient Echo—additional scan
completed in a subset only)
– 4 4 4 –
Mismatch negativity Computer task (C) Duration deviant passive auditory oddball task: ERP
recordings [55]
– 4 4 4 –
Working memory Computer task (C) Spatial N-Back task: functional MRI (variant of [124]) – 4 4 4 –
Attention Computer task (C) Auditory novelty oddball task: ERP recordings and functional
MRI (variant of [125])
– 4 4 4 –
Error-related processing Computer task (C) Go/No-Go task: ERP recordings and functional MRI [53] – 4 4 4 –
Response inhibition Computer task (C) Stop task: ERP recordings and functional MRI (variant of
[126])
– 4 4 4 –
Service use, support, and quality of life
Service utilisation Questionnaire (P, C) Services Assessment for Children and Adolescents [127] – – 4? – 4?
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Table 2 continued
Domain Assessment method
(informant)
Assessment
instrument
Assessment phase
SCR BL FU1 FU2 FU3a
Resource access Questionnaire (P, C) Resource Generator—UK, expert advice subscale [128] – – 4? – 4?
Social cohesion Questionnaire (P, C) Items assessing neighbourhood social cohesion [129] – – 4? – 4?
Peer interaction Questionnaire (C) Child Health and Illness Profile [130] peer interaction and
satisfaction scale
– – – – 4?
Mental health literacy Questionnaire (C) Self-report questionnaires on two vignettes depicting persons
with (1) depression and (2) psychosis. Assesses recognition
of the disorder, intended help-seeking, beliefs about
interventions and prevention, stigmatising attitudes, and
exposure to mental disorders [131]
– – – – 4?
Self-identification as
having a mental illness
Questionnaire (C) Self-Identification as Having a Mental Illness Scale (SELF-I)
assessing perceived need for professional help and appraisal
of problem as mental illness [132] adapted for young people
– – – – 4?
Stigma
Public stigma Questionnaire (P, C) Reported and Intended Behaviour Scale [133] – – 4? – 4?
Stigma coping Questionnaire (C) Items assessing cognitive appraisal of mental health stigma
[134]
– – – – 4?
Assessment phase—SCR screening assessment (age 9–11 years; data collected during 2005–2010 in 7966 children screened with questionnaires
at primary school), BL baseline assessment (age 9–12 years), FU1 follow-up assessment 1 at approximately 24-months post-baseline (age
11–14 years), FU2 follow-up assessment 2 at approximately 48-months post-baseline (age 13–16 years), FU3 follow-up assessment 3 at
approximately 72-months post-baseline (age 17–18 years; aself-report information only collected)
P primary caregiver, C child, T teacher
? Indicates measures collected in the longitudinal community cohort in addition to the longitudinal selected cohort
Total: 31.0% 
Boys: 30.8%
Girls: 30.9%
Total: 5.0% 
Boys: 4.8%
Girls: 5.3%
Total: 9.4% 
Boys: 13.4%
Girls: 5.8%
Total: 15.1% 
Boys: 13.0%
Girls: 17.1%
Total: 7.9% 
Boys: 9.6%
Girls: 6.4%
Total: 3.3% 
Boys: 5.1%
Girls: 1.6%
Total: 5.4% 
Boys: 5.6%
Girls: 5.2%
No antecedent:
Total: 22.9% 
Boys: 17.7%
Girls: 27.7%
Social, Emoonal, 
or Behavioural 
Problem
Psychoc-like 
Experience
Speech or motor delay 
or abnormality
Fig. 1 Venn diagram indicating
the percentages of children
displaying antecedents within
each domain of the triad
(overlapping segments indicate
children who displayed multiple
antecedents); based on data
from 1504 child–caregiver
dyads who completed screening
questionnaires
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schizophrenia on the screening questionnaires were simi-
larly elevated (3.4 % of children). The antecedent triad was
significantly more prevalent in males relative to females
(Fig. 1), and more common among children of African-
Caribbean [9, 17] and black African [9] ethnicity relative to
white British children, mimicking the increased incidence
of schizophrenia [18, 19] in these ethnic minority groups in
the UK. Conversely, children of south Asian ethnicity were
less likely relative to the white British population to present
the antecedent triad [9], providing a potential opportunity
to identify protective, as well as risk, processes that might
be operating prior to illness onset in schizophrenia.
Childhood PLEs
An early contribution from the CHADS programme was the
development of a nine-item self-report questionnaire
assessing a range of delusion- and hallucination-like expe-
riences for use by children aged 9-11 years [7], comprising
an adaption and extension of items from the Diagnostic
Interview Schedule for Children [20]. Almost two-thirds of
children reported at least one PLE, implying that these
experiences may be part of a spectrum of normative child-
hood experience in middle childhood [15]. Recent meta-
analyses indicate that auditory hallucinations are more
prevalent among children aged 9–12 years (median preva-
lence: 17 % [21]) than in the adolescent (7.5 %) or adult
(5–8 % [22]) general population, with questionnaire mea-
sures typically eliciting higher rates than clinical interviews
[23]. Discrepancy in our rates of self- and caregiver-reported
childhood PLEs (66.0 vs. 9.7 %; also reported by others [24,
25]) implies that children do not necessarily report these
phenomena to adults, or that they interpret their experiences
differently than do caregivers. Whilst the majority of chil-
dren reporting PLEs will not go on to develop a SSD in
adulthood, for many children, these experiences are not
benign; more than a third (40.9 %) reported distress or
functional impairment associated with these experiences,
particularly those presenting the antecedent triad (68.1 %
[9]). In children, similarly to the adult population [26], the
PLE items load on a construct which is correlated with, but
dissociable from, the constructs underpinning internalising
and externalising problems [15]. Two items assessing hal-
lucination-like experiences appeared most suited to identi-
fying children with vulnerability to psychotic illness in the
general population [15], with such items previously also
showing strong criterion validity for psychotic symptoms
elicited by diagnostic interview among 11–13-year olds [24].
Persistence of PLEs
Meta-analytic data approximate that 75–90 % of develop-
mental psychotic experiences are transitory and relatively
benign, but that these experiences may persist to become
clinically relevant, depending on the degree of environ-
mental risk to which the person is additionally exposed
[22]. Our longitudinal data indicated that two in five chil-
dren (39 %) who reported PLEs at baseline continued to
report these experiences approximately 2 years later, in
adolescence [27]. Persistent PLEs from childhood
(9–11 years) were associated with internalising and exter-
nalising psychopathology in adolescence [27], implying
that interventions targeting persistent PLEs might not only
alleviate risk for later schizophrenia, but more immedi-
ately, reduce common adolescent psychopathology.
Trajectories of psychopathology
Though PLEs and internalising and externalising psy-
chopathology in middle childhood all constitute replicated
antecedents of schizophrenia, our data indicate that inter-
nalising and externalising psychopathology experienced
only during childhood is not associated with increased risk
for PLEs in adolescence, whereas psychopathology that
persists from childhood into adolescence or is incident in
adolescence confers increased risk for later PLEs [28]. This
work suggests a need for further investigation into timely
targeted interventions designed to prevent progression from
early symptom development to full disorder.
Psychological, cognitive, and neurobiological
findings
Detailed, laboratory-based assessments have been con-
ducted biennially in the selected sample to determine the
extent to which hallmark disturbances of schizophrenia are
present already during the early (pre-prodromal) at-risk
phase of illness; findings to date are summarised in
Table 3.
Psychopathology and stress responsivity
Prospective longitudinal studies of both general population
[10] and familial high-risk [29] cohorts indicate psy-
chopathology during childhood and adolescence in indi-
viduals who later develop SSD. We investigated social
withdrawal in children with different vulnerability profiles
for the disorder, namely, children at putatively elevated
symptomatic risk of schizophrenia (ASz) and those at
elevated genetic risk due to a family history of illness
(FHx). Both ASz and FHx children aged 9–14 years pre-
sented significantly elevated levels of parent-reported
social withdrawal relative to their TD peers, though the
magnitude of the effect was greater among ASz children
[30]; thus, social withdrawal may be a more prominent
feature among children at elevated symptomatic risk.
482 Soc Psychiatry Psychiatr Epidemiol (2016) 51:475–491
123
With respect to their response to psychosocial stressors
(e.g. major life events, childhood trauma, and milder daily
hassles), which have been shown to contribute to the
development and maintenance of psychosis in retrospective
and prospective studies [31–33], FHx and ASz children
aged 11–14 years reported greater exposure to negative life
events and daily hassles, respectively, compared to TD
children, and were more distressed by these experiences
[34]. Thus, while both groups were more responsive to
psychosocial stressors, ASz and FHx children may be
susceptible to different stressors. Relative to TD children
[35], both risk groups experienced higher rates of physical
punishment (thought to be on a continuum with childhood
maltreatment, a replicated risk factor for SSD [36]).
Cognitive impairment
In light of meta-analytic data indicating premorbid IQ
impairment in children who later develop schizophrenia
[37], with low IQ increasing the risk of later schizophrenia
in a dose–response fashion [38], we investigated trajecto-
ries of neurocognitive function in children with different
vulnerability profiles. In initial cross-sectional analyses
conducted in ASz and TD groups only, we observed
impairments in general intelligence, verbal memory,
working memory, and executive function among ASz
children aged 9–12 years [39] which were less pervasive
and smaller in magnitude than those characterising adults
with schizophrenia [40], but similar to those observed
among CHR individuals [41, 42]. In subsequent analyses
performed on a larger, partially overlapping sample, ASz
children performed at a level intermediate to FHx children
with high familial loading (C1 first-degree or C2 second-
degree relatives) and FHx children with low familial
loading (one affected second-degree relative only) across a
range of neurocognitive subtests [43]. Preliminary analysis
of longitudinal data collected across three biennial assess-
ments spanning 9–16 years indicates different patterns of
Table 3 Summary of psychopathological, cognitive, neurobiological,
and HPA axis abnormalities observed among children presenting
antecedents of schizophrenia (ASz) and a family history of illness
(FHx) compared with the pattern of abnormalities typically observed
among adults with established psychosis
Marker Adult psychosis vs. HC ASz vs. TD children FHx vs. TD children
Psychopathology and stress responsivity
Social withdrawalb : : :
Psychosocial stress exposured : : :
Psychosocial stress reactivityd : : :
Cognitive impairmentsc
General intelligence (IQ) ; ; ;
Scholastic achievement ; ; ;
Verbal memory ; ; ;
Visual memory ; – –
Working memory (verbal) ; ; ;
Executive function (verbal fluency) ; ; ;
Executive function (inhibition) ; ; ;
Facial emotional processing ability ; ; Not examined
Neurobiological abnormalities
Grey matter volume (left STG/MTG and right MTG)a ; : ; Not examined
White matter volume (left SLF, ILF, and OR)a ; : Not examined
Error-related negativity ERP component amplitudea ; ; Not examined
Mismatch negativity ERP component amplitudea ; : Not examined
Dyskinetic movement abnormalitiesa : : Not examined
HPA axis dysfunction
Diurnal cortisold : – –
Cortisol awakening responsed ; – ;
Pituitary volumed : ; – –
HC healthy control, TD typically developing children, ; decreased in psychosis/high-risk group relative to HC/TD group; : Increased in
psychosis/high-risk group relative to HC/TD group, – no difference between psychosis/high-risk group and HC/TD group, STG superior temporal
gyrus, MTG medial temporal gyrus, SLF superior longitudinal fasciculus, ILF inferior longitudinal fasciculus, OR optic radiation, ERP event-
related potential, HPA hypothalamic–pituitary–adrenal
Encompassing CHADS assessments completed at age a 9–12 years, b 9–14 years, c 9–16 years, and d 11–14 years
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cognitive development through adolescence in ASz and
FHx children relative to TD children. ASz and FHx chil-
dren exhibited stable deficits in IQ, scholastic achievement,
verbal working memory, and specific domains of executive
function, but greater gains in verbal memory relative to
their TD peers [44], with relatively more subtle differences
apparent between the high risk groups (as has been indi-
cated also in meta-analysis of older samples of CHR youth
relative to youth with family history [45]). Our findings
highlight the uneven pace of development of different
cognitive abilities throughout adolescence in at-risk youth,
which might reflect divergence in the rate of maturation in
some brain areas among at-risk youth compared to their TD
peers.
The cognitive impairments characterising ASz children
also extend to social cognition. Consistent with the
impaired ability of individuals with schizophrenia [46] and
CHR youth [47] to recognise facial emotions, ASz children
(9–15 years) showed moderate deficits in facial emotion
recognition, particularly sad and angry expressions [48].
Future analyses will examine whether these facial emotion
processing deficits also characterise FHx children; previous
investigations of older youth (13–25 years) indicate that
such impairments are more prominent among CHR indi-
viduals than those with family history of schizophrenia
[49].
Neurobiological abnormalities
Antipsychotic medication and neurodegenerative processes
associated with disease progression potentially confound
neurobiological studies of adults with established
schizophrenia, and only the latter are overcome in studies
of CHR youth (a substantial proportion of whom also
receive psychotropic treatment [50]). Our work examining
medication-naive at-risk children thus offers important
insights into the aetiology of neurobiological abnormalities
underlying schizophrenia.
We have shown that a subset of the structural brain
abnormalities associated with schizophrenia (typically,
widespread volume decreases, but also increases, encom-
passing the frontal and temporal lobes, medial temporal
regions, anterior cingulate, insula, and thalamus [51])
precede the prodromal phase of illness. By age 9–12 years,
ASz children present significant grey matter volume
reduction in the right middle temporal gyrus, but significant
volume increase in the left superior and middle temporal
gyri relative to TD children [52]. ASz children also show
increased white matter volume in the left inferior parietal
lobe, occipital lobe, and superior temporal gyrus, corre-
sponding to parts of the superior longitudinal fasciculus,
inferior longitudinal fasciculus, and optic radiation. Whilst
these abnormalities contrast with temporal lobe volume
reductions typically reported in schizophrenia, our findings
imply that changes in this region may be among the first
structural brain abnormalities to emerge. Our longitudinal
data will allow us to track further structural changes
through adolescence to illness onset.
Abnormalities of brain function that characterise adults
with schizophrenia, as indexed by event-related potentials
(ERP), are present also in ASz children. We have investi-
gated two well-defined ERP components at 9–12 years:
error-related negativity (ERN), a brain potential elicited
following detection of an error, and auditory mismatch
negativity (MMN), an ERP component that reflects an
automatic attentive process detecting discrepancy between
an incoming sound and the memory trace of preceding
sounds. Similar to patients with schizophrenia, ASz chil-
dren showed reduced amplitude of the ERN component
[53]. It is proposed that the ERN is generated to an error
following a dopamine-mediated negative reinforcement
learning signal sent from the basal ganglia to the anterior
cingulate cortex [54]; thus, reduced ERN in schizophrenia
(and ASz children) might reflect disruption of these
dopamine pathways. In contrast with the decreased MMN
amplitude typically observed in schizophrenia, however,
ASz children were characterised by increased MMN
amplitude relative to TD children [55], indicating the need
for longitudinal data to establish the developmental tra-
jectory of this component in at-risk children.
We have further demonstrated that involuntary dyski-
netic movements, thought to index the abnormal striatal
dopamine levels that characterise individuals with
schizophrenia, are more frequent among ASz children aged
9–12 years compared to TD children [56]. These abnor-
malities (rated blindly using videotapes) were observed in
the facial regions (e.g. tics, grimacing) and upper body
(e.g. shoulder/hip torsion, finger or wrist extensions) and
are similar to those reported among children who later
develop schizophrenia [57, 58] and adolescents with
schizotypal personality disorder [59].
Hypothalamic–pituitary–adrenal (HPA) axis dysfunction
Our study of medication-naı¨ve, non-help-seeking children
has also allowed us to investigate whether abnormalities
within the HPA axis (the primary system involved in
coordinating the physiological response to stress), which
have been observed among first-episode psychosis patients
and CHR youth [60–63], also characterise earlier stages of
illness. It is hypothesised that, among individuals at
increased vulnerability for psychosis, HPA axis hyperac-
tivity (triggered by psychosocial stress) elicits elevated
cortisol levels, which in turn contribute to the clinical
features of psychosis by augmenting dopamine activity [64,
65]. However, HPA abnormalities reported among first-
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episode and CHR patients [including elevated daytime
cortisol levels, a blunted cortisol awakening response
(CAR), and pituitary volume enlargements] might simply
be a consequence of the stress associated with emerging
illness.
By age 11–14 years, FHx children (but not ASz chil-
dren) showed a blunted CAR [43] that was not explained
by experiences of psychosocial stressors and was more
prominent among FHx children with a first-degree relative
with schizophrenia than among FHx with an affected sec-
ond-degree relative. In contrast to hypotheses, neither ASz
nor FHx children were characterised by higher diurnal
cortisol levels. Nonetheless, among both FHx and ASz
children, abnormal cortisol levels (i.e. higher diurnal cor-
tisol levels and greater blunting of the CAR) were associ-
ated with poorer memory and executive function, possibly
reflecting underlying dysfunction in the brain regions
which mediate both HPA axis function and these cognitive
functions [43]. Neither ASz nor FHx children were char-
acterised by pituitary volume enlargements [35], which
contrasts with those identified among individuals with first-
episode psychosis [66–69] and in some (but not all) studies
of older individuals at-risk for psychosis [69, 70]. Among
FHx children only, pituitary volume was negatively asso-
ciated with current distress relating to negative life events
and exposure to physical punishment [35], implying that
psychosocial stressors may contribute to pituitary volume
changes among those with family history. Overall, our
findings tentatively suggest that the blunted CAR might be
an early (possibly genetically mediated) marker of psy-
chosis vulnerability, while HPA axis hyperactivity (as
indexed by elevated daytime cortisol levels and enlarged
pituitary volume) might emerge closer to disease onset.
Intervention findings
Many children and adolescents experiencing mental health
difficulties do not receive appropriate professional care [71,
72]. Data from the CHADS longitudinal community cohort
have highlighted the central role of caregivers’ attitudes
and experiences on young people’s service use (in health
and education settings), particularly the influence of care-
givers’ perceptions of stigma and their own service use
history [73]. Targeting stigma among caregivers may be a
key strategy in bridging the gap between young people’s
need and service use.
We have developed a cognitive behavioural intervention
for children aged 9–14 years who experience PLEs and
emotional problems which is designed to reduce emotional
symptoms, improve coping and resilience, and help chil-
dren manage distressing PLEs [74]. In a pilot with four
children, child and therapist satisfaction with the pro-
gramme was high, and emotional problems and PLE
frequency and impact all decreased during intervention. A
randomised controlled evaluation of the intervention with
clinically referred samples of children is underway
(Table 1, ‘‘4. CHADS-associated intervention samples’’).
Distressing PLEs are common in these children. In pre-
treatment data, negative life events, emotional symptoms,
cognitive biases (e.g. probabilistic reasoning and jumping
to conclusions biases), and negative schematic beliefs
about self and others independently contributed to PLE
severity [75, 76]. Further, negative schematic beliefs
mediated the relationship between experiences of bullying
and PLEs [77]. These psychosocial and cognitive processes
show different associations with PLE content (e.g. para-
noia, hallucinations) and dimensional attributes (e.g. fre-
quency, impact) [78] and provide potential targets for
psychological intervention in children with PLEs.
Discussion
The CHADS programme, encompassing complementary
community and selected cohorts, has yielded findings that
may aid efforts to delineate the aetiological processes
underlying SSD, and inform strategies to identify and treat
at-risk individuals earlier than is currently feasible.
Building on the work of early prospective longitudinal
studies of both general population and familial high-risk
cohorts (which were typically restricted to examination of
psychopathological features), we have identified several
neurobiological markers that may index early, premorbid
pathophysiology on a developmental trajectory to SSD. By
means of our large, unselected sample (from an ethnically
diverse, urban population), we have contributed epidemi-
ological findings demonstrating that the prevalence of the
triad of schizophrenia antecedents is elevated among males
and specific ethnic groups, and that PLEs in particular can
be distressing and persistent for some children, depending
on co-occurrence of internalising and externalising symp-
toms or other antecedents of schizophrenia. Furthermore,
in a clinically referred sample of children, we have shown
that levels of distress and severity associated with PLEs are
related to psychological and cognitive constructs that may
be amenable to cognitive-behavioural interventions.
Scientific and theoretical advancements
Aetiological theories
Our findings align with the recent sociodevelopmental-
cognitive model of schizophrenia [79] that integrates
dopaminergic, neurodevelopmental, sociodevelopmental,
and cognitive theories. Whilst it has long been suspected
that schizophrenia is preceded by abnormal
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neurodevelopment commencing in early life, prospective
studies utilising magnetic resonance imaging and ERP
technology have been lacking. Our work has provided
preliminary evidence that several structural [52] and
functional brain abnormalities [53, 55] associated with
schizophrenia are evident in at-risk children by age
9–12 years. Moreover, increased dyskinetic movements
[56] and reduced amplitude of the ERN brain potential [53]
in ASz children hint at early abnormalities in dopamine
regulation. In line with the cognitive component of the
model, our work in clinically referred children has indi-
cated a number of cognitive biases associated with PLEs
[75, 76]. We have identified a number of potential social
adversities which might contribute to such biases (e.g.
physical punishment [35], negative life events, and daily
hassles [34]) that are more prevalent and elicit greater
distress in at-risk children than typically developing chil-
dren. Whilst we have found no evidence as yet that these
stressful experiences elicit HPA axis abnormalities in ASz
and FHx children [35, 43], developmental changes may
render the HPA axis more susceptible to environmental
stressors. Thus, many of the components within the
sociodevelopmental-cognitive model of schizophrenia [79]
that are hypothesised to contribute to the development of
schizophrenia are detectable in at-risk children, but further
work is required to integrate these findings for testing.
Genetically and symptomatically driven risk markers
The CHADS findings augment those of previous longitudi-
nal studies, commencing in the 1950s, which prospectively
followed offspring of parents with schizophrenia [29]. We
offer evidence confirming neurocognitive impairments and
social withdrawal in young relatives of individuals with
schizophrenia [80–82], and new findings regarding experi-
ences of psychosocial stress and HPA axis function in FHx
children (which, until now, have been studied only in adult
relatives who may no longer be ‘at-risk’ for the disorder). By
characterising development of both ASz and FHx children,
we may identify risk markers that are primarily genetically
mediated (and may be shared by non-symptomatic relatives),
and others present only in individuals displaying the ante-
cedent phenotype [83]. The latter offers the prospect of
identifying candidate mechanisms associated with emerging
illness. Future investigations might benefit from incorpo-
rating at-risk groups identified by alternative means (e.g.
youth with a family history of bipolar disorder or those with
22q11.2 deletion syndrome).
Timing and trajectories
To date, we have investigated only a subset of the potential
markers that may be affected in at-risk children, and while
many of these markers have shown abnormalities that are
similar to those observed in adults with schizophrenia and
CHR youth, there are notable exceptions. For example,
ASz children were characterised by increased amplitude of
the MMN potential [55], and relative increases in grey and
white matter in the temporal lobes [52]; it is possible that
these patterns may reverse as the brain undergoes matu-
ration in adolescence. Our investigations revealed no evi-
dence of anticipated abnormalities such as elevated diurnal
cortisol [43] or pituitary volume enlargement [35] among
either ASz or FHx children, implying that HPA axis
hyperactivity may emerge more proximally to illness onset.
Having identified potential premorbid markers of illness
(albeit these must be shown to be robust with replication in
other samples), an important next step will be to determine
whether these markers vary with symptom fluctuation and
are responsive to intervention. Studies that assess changes
in both biological and psychological markers in response to
intervention are needed.
Implications
The psychosocial, cognitive, and neurobiological features
that we have found to characterise ASz and FHx children
might potentially be used to enhance the accuracy with
which individuals at-risk of SSD can be identified in the
general population and/or via relatives with SSD. We
anticipate that, instead of SSD, some putatively at-risk
children will develop other psychiatric disorders, whilst
others will develop no disorder. Longitudinal follow-up of
the cohort is needed to determine the specificity and sen-
sitivity with which the antecedent triad and associated
psychopathological markers distinguish between these
outcomes. From a clinical perspective, our findings have
already informed the development of a new psychological
intervention for children aged 8–14 years which targets
current difficulties experienced by the children (e.g. dis-
tressing PLEs and emotional symptoms [74]). We hope that
such intervention might also avert more serious mental
health problems in the future.
Research into the early identification and prevention of
SSD has focussed predominantly on youth in late adoles-
cence or early adulthood who present features consistent
with the prodromal phase of illness immediately preceding
psychosis onset, with little consideration given to vulner-
able children or younger adolescents in an earlier phase of
illness. Our research demonstrates that this group, who may
present different clinical and biological features and
treatment needs to those meeting CHR criteria [84], should
not be overlooked. Indeed, children presenting multiple
antecedents of schizophrenia present a range of social,
psychological, cognitive, and biological abnormalities
characteristic of adults with schizophrenia, though they are
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(at present) less marked and diffuse, thereby providing a
potential window for early intervention. Our new method of
screening community samples to identify children display-
ing multiple antecedents of schizophrenia (who are puta-
tively in the premorbid illness phase) offers a tool to facilitate
research, and might, with refinements informed by ongoing
research, complement established methods for identifying
CHR youth in the later, prodromal phase of illness. Further
research across the CHADS cohorts is underway to: (1)
characterise developmental changes through adolescence
and into young adulthood that might constitute viable targets
for early preventative interventions, (2) identify neurobio-
logical, neurocognitive, and psychopathological changes
that might signal imminent risk of transition to psychosis,
and (3) develop novel, innovative interventions that might
alter the course of illness in vulnerable individuals. Through
these research endeavours, we hope ultimately to improve
outcomes for individuals who may be on the trajectory to this
devastating disorder.
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